Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Lou Gehrigs Disease industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Q-Therapeutics Inc
Pharnext SAS
GlaxoSmithKline plc
Cytokinetics Inc
Ionis Pharmaceuticals, Inc
Covis Pharmaceutical Inc
Mitsubishi Tanabe Pharma Corp
Avicena Group
Neuraltus Pharmaceuticals Inc
BrainStorm Therapeutics
Biogen
Neuralstem Inc
Eisai Co Ltd
By Type:
Riluzole
Edaravone (Radicava)
By Application:
Hospital Pharmacies
Retail & Online Pharmacie
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Lou Gehrigs Disease Market Overview 2018-2029
-
1.1 China Lou Gehrigs Disease Industry Development Overview
-
1.2 China Lou Gehrigs Disease Industry Development History
-
1.3 China Lou Gehrigs Disease Industry Market Size (2018-2029)
-
1.4 China Lou Gehrigs Disease Market Analysis by Type from Production Side
-
1.4.1 China Lou Gehrigs Disease Production Volume, Production Value and Growth Rate of Riluzole (2018-2029)
-
1.4.2 China Lou Gehrigs Disease Production Volume, Production Value and Growth Rate of Edaravone (Radicava) (2018-2029)
-
1.5 China Lou Gehrigs Disease Market Analysis by Application from Consumption End
-
1.5.1 China Lou Gehrigs Disease Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.2 China Lou Gehrigs Disease Sales Volume, Sales Value and Growth Rate of Retail & Online Pharmacie (2018-2029)
-
1.6 China Lou Gehrigs Disease Market Analysis by Region
-
1.6.1 North China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
Chapter 2 China Lou Gehrigs Disease Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Lou Gehrigs Disease Market Status and Competition at home and abroad in 2023
-
2.2.2 China Lou Gehrigs Disease Market Status and Competition Analysis in 2023
-
2.2.3 China Lou Gehrigs Disease Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Lou Gehrigs Disease Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Lou Gehrigs Disease Industry Development
Chapter 3 Lou Gehrigs DiseaseIndustry Chain Analysis
-
3.1 Lou Gehrigs Disease Industry Chain
-
3.2 Lou Gehrigs Disease Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Lou Gehrigs Disease Market
-
3.3 Lou Gehrigs Disease Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Lou Gehrigs Disease Market
Chapter 4 China Lou Gehrigs Disease Market, by Type
-
4.1 China Lou Gehrigs Disease Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Lou Gehrigs Disease Total Production Volume and Growth Rate from Production Side
-
4.5 China Lou Gehrigs Disease Production Volume and Growth Rate, by Type
-
4.5.1 China Lou Gehrigs Disease Production Volume and Growth Rate of Riluzole
-
4.5.2 China Lou Gehrigs Disease Production Volume and Growth Rate of Edaravone (Radicava)
Chapter 5 China Lou Gehrigs Disease Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Lou Gehrigs Disease Total Market Size and Growth Rate from Consumption End
-
5.5 China Lou Gehrigs Disease Market Size and Growth Rate, by Application
-
5.5.1 China Lou Gehrigs Disease Market Size and Growth Rate of Hospital Pharmacies
-
5.5.2 China Lou Gehrigs Disease Market Size and Growth Rate of Retail & Online Pharmacie
Chapter 6 China Lou Gehrigs Disease Market, by Region
-
6.1 China Lou Gehrigs Disease Production Volume and Production Value, by Region
-
6.2 China Lou Gehrigs Disease Sales Volume and Sales Value, by Region
Chapter 7 North China Lou Gehrigs Disease Market Analysis
-
7.1 North China Lou Gehrigs Disease Market, by Type
-
7.2 North China Lou Gehrigs Disease Market, by Application
Chapter 8 Central China Lou Gehrigs Disease Market Analysis
-
8.1 Central China Lou Gehrigs Disease Market, by Type
-
8.2 Central China Lou Gehrigs Disease Market, by Application
Chapter 9 South China Lou Gehrigs Disease Market Analysis
-
9.1 South China Lou Gehrigs Disease Market, by Type
-
9.2 South China Lou Gehrigs Disease Market, by Application
Chapter 10 East China Lou Gehrigs Disease Market Analysis
-
10.1 East China Lou Gehrigs Disease Market, by Type
-
10.2 East China Lou Gehrigs Disease Market, by Application
Chapter 11 Northeast China Lou Gehrigs Disease Market Analysis
-
11.1 Northeast China Lou Gehrigs Disease Market, by Type
-
11.2 Northeast China Lou Gehrigs Disease Market, by Application
Chapter 12 Southwest China Lou Gehrigs Disease Market Analysis
-
12.1 Southwest China Lou Gehrigs Disease Market, by Type
-
12.2 Southwest China Lou Gehrigs Disease Market, by Application
Chapter 13 Northwest China Lou Gehrigs Disease Market Analysis
-
13.1 Northwest China Lou Gehrigs Disease Market, by Type
-
13.2 Northwest China Lou Gehrigs Disease Market, by Application
Chapter 14 Company Profiles
-
14.1 Q-Therapeutics Inc
-
14.1.1 Q-Therapeutics Inc Company Profile
-
14.1.2 Q-Therapeutics Inc Lou Gehrigs Disease Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pharnext SAS
-
14.2.1 Pharnext SAS Company Profile
-
14.2.2 Pharnext SAS Lou Gehrigs Disease Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 GlaxoSmithKline plc
-
14.3.1 GlaxoSmithKline plc Company Profile
-
14.3.2 GlaxoSmithKline plc Lou Gehrigs Disease Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Cytokinetics Inc
-
14.4.1 Cytokinetics Inc Company Profile
-
14.4.2 Cytokinetics Inc Lou Gehrigs Disease Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Ionis Pharmaceuticals, Inc
-
14.5.1 Ionis Pharmaceuticals, Inc Company Profile
-
14.5.2 Ionis Pharmaceuticals, Inc Lou Gehrigs Disease Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Covis Pharmaceutical Inc
-
14.6.1 Covis Pharmaceutical Inc Company Profile
-
14.6.2 Covis Pharmaceutical Inc Lou Gehrigs Disease Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Mitsubishi Tanabe Pharma Corp
-
14.7.1 Mitsubishi Tanabe Pharma Corp Company Profile
-
14.7.2 Mitsubishi Tanabe Pharma Corp Lou Gehrigs Disease Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Avicena Group
-
14.8.1 Avicena Group Company Profile
-
14.8.2 Avicena Group Lou Gehrigs Disease Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Neuraltus Pharmaceuticals Inc
-
14.9.1 Neuraltus Pharmaceuticals Inc Company Profile
-
14.9.2 Neuraltus Pharmaceuticals Inc Lou Gehrigs Disease Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 BrainStorm Therapeutics
-
14.10.1 BrainStorm Therapeutics Company Profile
-
14.10.2 BrainStorm Therapeutics Lou Gehrigs Disease Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Biogen
-
14.11.1 Biogen Company Profile
-
14.11.2 Biogen Lou Gehrigs Disease Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Neuralstem Inc
-
14.12.1 Neuralstem Inc Company Profile
-
14.12.2 Neuralstem Inc Lou Gehrigs Disease Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Eisai Co Ltd
-
14.13.1 Eisai Co Ltd Company Profile
-
14.13.2 Eisai Co Ltd Lou Gehrigs Disease Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Lou Gehrigs Disease Industry Research Conclusions
-
15.2 Lou Gehrigs Disease Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Lou Gehrigs Disease Industry Market Size (2018-2029)
-
Figure China Lou Gehrigs Disease Production Volume, Production Value and Growth Rate of Riluzole (2018-2029)
-
Figure China Lou Gehrigs Disease Production Volume, Production Value and Growth Rate of Edaravone (Radicava) (2018-2029)
-
Figure China Lou Gehrigs Disease Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Lou Gehrigs Disease Sales Volume, Sales Value and Growth Rate of Retail & Online Pharmacie (2018-2029)
-
Figure North China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
Figure Central China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
Figure South China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
Figure East China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Lou Gehrigs Disease Market Size and Growth Rate from 2018-2029
-
Figure Lou Gehrigs Disease Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Lou Gehrigs Disease Market Share by Type in 2018
-
Figure China Lou Gehrigs Disease Market Share by Type in 2023
-
Figure China Lou Gehrigs Disease Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Lou Gehrigs Disease Production Volume and Growth Rate of Riluzole (2018-2023)
-
Figure China Lou Gehrigs Disease Production Volume and Growth Rate of Edaravone (Radicava) (2018-2023)
-
Figure China Lou Gehrigs Disease Market Share by Application in 2018
-
Figure China Lou Gehrigs Disease Market Share by Application in 2023
-
Figure China Lou Gehrigs Disease Total Market Size and Growth Rate from Consumption End
-
Figure China Lou Gehrigs Disease Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Lou Gehrigs Disease Market Size and Growth Rate of Retail & Online Pharmacie (2018-2023)
-
Table China Lou Gehrigs Disease Production Volume by Region (2018-2023)
-
Table China Lou Gehrigs Disease Production Volume Share by Region (2018-2023)
-
Figure China Lou Gehrigs Disease Production Volume Share by Region (2018-2023)
-
Table China Lou Gehrigs Disease Production Value by Region (2018-2023)
-
Table China Lou Gehrigs Disease Production Value Share by Region (2018-2023)
-
Figure China Lou Gehrigs Disease Production Value Share by Region (2018-2023)
-
Table China Lou Gehrigs Disease Sales Volume by Region (2018-2023)
-
Table China Lou Gehrigs Disease Sales Volume Share by Region (2018-2023)
-
Figure China Lou Gehrigs Disease Sales Volume Share by Region (2018-2023)
-
Table China Lou Gehrigs Disease Sales Value by Region (2018-2023)
-
Table China Lou Gehrigs Disease Sales Value Share by Region (2018-2023)
-
Figure China Lou Gehrigs Disease Sales Value Share by Region (2018-2023)
-
Table North China Lou Gehrigs Disease Production Volume by Type (2018-2023)
-
Table North China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Figure North China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Table North China Lou Gehrigs Disease Sales Volume by Application (2018-2023)
-
Table North China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Figure North China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Table Central China Lou Gehrigs Disease Production Volume by Type (2018-2023)
-
Table Central China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Figure Central China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Table Central China Lou Gehrigs Disease Sales Volume by Application (2018-2023)
-
Table Central China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Figure Central China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Table South China Lou Gehrigs Disease Production Volume by Type (2018-2023)
-
Table South China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Figure South China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Table South China Lou Gehrigs Disease Sales Volume by Application (2018-2023)
-
Table South China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Figure South China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Table East China Lou Gehrigs Disease Production Volume by Type (2018-2023)
-
Table East China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Figure East China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Table East China Lou Gehrigs Disease Sales Volume by Application (2018-2023)
-
Table East China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Figure East China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Table Northeast China Lou Gehrigs Disease Production Volume by Type (2018-2023)
-
Table Northeast China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Figure Northeast China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Table Northeast China Lou Gehrigs Disease Sales Volume by Application (2018-2023)
-
Table Northeast China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Table Southwest China Lou Gehrigs Disease Production Volume by Type (2018-2023)
-
Table Southwest China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Figure Southwest China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Table Southwest China Lou Gehrigs Disease Sales Volume by Application (2018-2023)
-
Table Southwest China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Table Northwest China Lou Gehrigs Disease Production Volume by Type (2018-2023)
-
Table Northwest China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Figure Northwest China Lou Gehrigs Disease Production Volume Share by Type (2018-2023)
-
Table Northwest China Lou Gehrigs Disease Sales Volume by Application (2018-2023)
-
Table Northwest China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Lou Gehrigs Disease Sales Volume Share by Application (2018-2023)
-
Table Q-Therapeutics Inc Company Profile
-
Table Q-Therapeutics Inc Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Pharnext SAS Company Profile
-
Table Pharnext SAS Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Cytokinetics Inc Company Profile
-
Table Cytokinetics Inc Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Ionis Pharmaceuticals, Inc Company Profile
-
Table Ionis Pharmaceuticals, Inc Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Covis Pharmaceutical Inc Company Profile
-
Table Covis Pharmaceutical Inc Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Mitsubishi Tanabe Pharma Corp Company Profile
-
Table Mitsubishi Tanabe Pharma Corp Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Avicena Group Company Profile
-
Table Avicena Group Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Neuraltus Pharmaceuticals Inc Company Profile
-
Table Neuraltus Pharmaceuticals Inc Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table BrainStorm Therapeutics Company Profile
-
Table BrainStorm Therapeutics Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Biogen Company Profile
-
Table Biogen Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Neuralstem Inc Company Profile
-
Table Neuralstem Inc Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
Table Eisai Co Ltd Company Profile
-
Table Eisai Co Ltd Lou Gehrigs Disease Revenue, Price and Gross (2018-2023)
-
